Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  Hedgehog inhibitor PF-04449913
Find trials that include:  Any drugs shown
Results 1-5 of 5 for your search:
Start Over
A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: B1371003, NCI-2012-01145, 2012-000684-24, NCT01546038
PF-04449913 in Treating Patients with Acute Leukemia or Myelodysplastic Syndromes at High Risk of Relapse after Donor Stem Cell Transplant
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 12-1558, NCI-2013-00824, 12-1558.cc, NCT01841333
Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS)
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 17302, NCI-2013-01758, NCT01842646
A Combination Study of PF-04449913 and Azacitidine In 1st Line MDS, AML and CMML Patients
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: B1371012, NCI-2015-00462, 2014-001345-24, NCT02367456
PF-04449913 Single-Agent In Patients With Myelofibrosis Previously Treated With a Janus Kinase Inhibitor
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: B1371013, NCI-2014-02538, 2014-000933-21, 2014-001048-40, SMOI, NCT02226172
Start Over